Collectively, these data suggest that the PKM2 tetramer agonist TEPP-46 protects mice from endotoxemia and sepsis induced by LPS or CLP by reducing the release of TNF-α and IL-6. This evidence concerns the gene PKM and serum lipopolysaccharide activity.